$HHSE: SNAPSHOT INTO Q1, 2019 - What is HHSE anti
Post# of 5409
5a). MAJOR THEATRICALS - We anticipate a "major" theatrical release occurring during February 2019 (500+ screens). We believe that this title will be the first of FOUR (4) major films for HHSE to handle theatrically during 2019 - and that the revenue potential is in the multiple-millions.
5b). MAJOR PRODUCTIONS - We anticipate THREE (3) Major Productions will be fully funded during Q1 - with TWO of them going in to production on or before April 1, 2019. These titles have been structured to cover HHSE overhead and operating costs... as well as to generate lucrative distribution fees and theatrical marketing service income.
5c). MYFLIX GROWTH - With a monthly break-even of only 12,000 subscribers (at $8 each) or 30,000 total TVOD Transactions (or a mixture of both revenue streams), MyFlix is anticipated to be Cash-Flow Positive within 90-days of initial consumer launch. Comparable sites, such as Acorn.TV have over 700,000 monthly subscribers (generating almost $100-mm per year in gross subscription revenues). So, we are optimistic that MyFlix has the potential to be a major venture and cash-flow generator for HHSE as quickly as April of 2019.
5d). CORPORATE FINANCING - Discussions have been ongoing with several high net-worth investors and funds to finance a "shelf-registration" for HHSE following the Form 10 Registration. At a target price of $.10 per share, HHSE could receive a direct cash infusion of up to $8-mm for a 10% stake from these long-term strategic sources... providing liquidity and opportunity that the company has literally never enjoyed. With the company being fully reporting, having shed the majority of debts currently being carried on the balance sheet, having new success with higher-profile theatrical releases and productions... and making consumer waves and revenues through MyFlix... the timing for a major raising in early 2019 may make a lot of sense... stay tuned!